Toshiba upgrades Artida cardiac ultrasound

Toshiba America Medical Systems showcased its newest additions to the Aplio Artida ultrasound system and introduced a pediatric package and two new probes for the product at the American College of Cardiology (ACC) annual meeting in Orlando, Fla., this week.

The company also highlighted two new software upgrades designed to improve its 3D and 2D wall motion tracking, enabling physicians to assess live 3D volume images in one cardiac cycle.

Using Artida's real-time, multi-planar reformatting capabilities, physicians can assess global and regional left ventricular (LV) function, including volumetric LV ejection fraction. Arbitrary views of the heart, not available in 2D imaging, are also obtained to help with surgical planning. The 2D/3D wall motion tracking features allow the user to obtain angle-independent, global and regional information about myocardial contraction, the company said.

Toshiba said it hopes these features will enable acquisition of additional data that could be of value in echo-guided cardiac resynchronization therapy and in stress echocardiography.

In addition to the 3D and 2D wall motion tracking upgrades, Toshiba has expanding the clinical applications for ultrasound in pediatric care with new a pediatric package and two new probes. The new pediatric probes will provide higher transducer frequencies for pediatrics, according to the company.



Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.